You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atopic Dermatitis of the upper limb

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis Trial in United States (Difamilast, Placebo)

Recruiting
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +36 more
Jan 31, 2023

Associated Burden of Related Conditions in Alopecia Areata

Completed
  • Alopecia Areata
  • +35 more
  • Exposure of interest (studies 2 & 3).
  • London, United Kingdom
    Momentum Data Ltd
Dec 13, 2022

Atopic Dermatitis Trial in Evansville, Anderson, Murfreesboro (Difamilast)

Recruiting
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +47 more
Jan 31, 2023

Atopic Dermatitis Trial in United States (B244, Vehicle)

Completed
  • Atopic Dermatitis
  • B244
  • Vehicle
  • Birmingham, Alabama
  • +50 more
Jun 1, 2022

Atopic Dermatitis Trial in United States (Lebrikizumab, Placebo)

Completed
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +84 more
Oct 20, 2022

Dermatitis, Atopic Trial in Canada, United States (Dupilumab)

Active, not recruiting
  • Dermatitis, Atopic
  • Birmingham, Alabama
  • +77 more
Jun 10, 2022

Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo)

Completed
  • Atopic Dermatitis
  • Lebrikizumab
  • Placebo
  • Scottsdale, Arizona
  • +88 more
Jun 17, 2022

Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

Not yet recruiting
  • Atopic Dermatitis
  • Baricitinib 4 MG
  • Azathioprine 1.5-2.5 mg/kg
  • Sari, Mazandaran, Iran, Islamic Republic of
    Iran
Aug 1, 2023

Atopic Dermatitis Trial in Shenyang, Jinan (1.5% QLM3003, 2% QLM3003, Vehicle (Placebo))

Not yet recruiting
  • Atopic Dermatitis
  • 1.5% QLM3003
  • +2 more
  • Shenyang, Liaoning, China
  • +1 more
Sep 21, 2023

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Caba, Buenos Aires, Argentina
  • +184 more
Jun 7, 2022

Atopic Dermatitis Trial in China (CBP-201)

Not yet recruiting
  • Atopic Dermatitis
  • Beijing, Beijing, China
  • +40 more
Jun 14, 2023

Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)

Recruiting
  • Atopic Dermatitis
  • UCB1381
  • Placebo
  • Glendale, California
    Up0110 101
Jan 20, 2023

Atopic Dermatitis Trial in Osasco (Mometasone Furoate)

Recruiting
  • Atopic Dermatitis
  • Mometasone Furoate
  • Osasco, São Paulo, Brazil
    Dr Sérgio Sckalka
May 28, 2021

Atopic Dermatitis Trial in United States (nemolizumab (CIM331), Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • nemolizumab (CIM331)
  • Placebo
  • Anniston, Alabama
  • +17 more
Jan 18, 2022

Atopic Dermatitis Trial in Denver, Montreal (Dupilumab SAR231893)

Completed
Has Results
  • Atopic Dermatitis
  • Dupilumab SAR231893
  • Denver, Colorado
  • +1 more
Jul 19, 2022

Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

Not yet recruiting
  • Atopic Dermatitis
  • Dupilumab - Discontinuation
  • +2 more
  • (no location specified)
Nov 2, 2023

Atopic Dermatitis Trial in Germany, United States (Pimecrolimus, Topical corticosteroids)

Completed
Has Results
  • Atopic Dermatitis
  • Phoenix, Arizona
  • +30 more
Feb 4, 2022

Moderate-to-severe Atopic Dermatitis Trial in Beijing (CM326, Placebo)

Recruiting
  • Moderate-to-severe Atopic Dermatitis
  • CM326
  • Placebo
  • Beijing, China
    Peking University People's hospital
Dec 31, 2022

Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo, Topical Corticosteroid)

Completed
Has Results
  • Atopic Dermatitis
  • Lebrikizumab
  • +2 more
  • Scottsdale, Arizona
  • +62 more
May 5, 2022

Atopic Dermatitis Trial

Not yet recruiting
  • Atopic Dermatitis
    • (no location specified)
    Nov 16, 2023

    Dermatitis, Atopic Trial in China (611 150mg, 611 300mg, 611 600mg)

    Completed
    • Dermatitis, Atopic
    • 611 150mg
    • +3 more
    • Wuhu, Anhui, China
    • +4 more
    Nov 30, 2022

    Atopic Dermatitis, Eczema Trial (Lebrikizumab)

    Not yet recruiting
    • Atopic Dermatitis
    • Eczema
    • Lebrikizumab
    • (no location specified)
    Aug 7, 2023

    Dermatitis, Atopic Trial in High Point (Wash IP, Cream IP)

    Not yet recruiting
    • Dermatitis, Atopic
    • Wash IP
    • Cream IP
    • High Point, North Carolina
      Dermatology Consulting Services, PLLC
    Aug 9, 2022

    Atopic Dermatitis Trial (ADX-914, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • (no location specified)
    Aug 18, 2022

    Atopic Dermatitis Trial in Shanghai (0.1% QY211 Gel or , 0.3% QY211 Gel or , 0.8% QY211 Gel or )

    Recruiting
    • Atopic Dermatitis
    • 0.1% QY211 Gel or placebo
    • +3 more
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Apr 24, 2023